Charles Rhyee
Stock Analyst at TD Cowen
(3.90)
# 1,794
Out of 4,442 analysts
651
Total ratings
50%
Success rate
4%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintained: Buy | $1,012 | $744.85 | +35.87% | 49 | Jun 18, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $65 → $81 | $67.20 | +20.54% | 11 | Jun 18, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $235 | $181.56 | +29.43% | 22 | Jun 4, 2026 | |
| VEEV Veeva Systems | Maintained: Buy | $300 → $235 | $153.16 | +53.43% | 20 | Jun 4, 2026 | |
| COR Cencora | Rated: Buy | $400 | $271.28 | +47.45% | 50 | Jun 1, 2026 | |
| ICLR ICON Public Limited Company | Rated: Buy | $120 → $164 | $140.73 | +16.54% | 19 | Jun 1, 2026 | |
| MDRX Veradigm Inc. | Reiterated: Buy | $8 | $5.00 | +60.00% | 21 | May 27, 2026 | |
| DRIO DarioHealth | Maintained: Hold | $11 | $6.43 | +71.07% | 17 | May 13, 2026 | |
| CVS CVS Health | Reiterated: Buy | $105 → $110 | $101.30 | +8.59% | 58 | May 11, 2026 | |
| EVH Evolent Health | Maintained: Buy | $7 → $8 | $4.48 | +78.57% | 48 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 → $4 | $2.57 | +55.64% | 36 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $34.71 | +52.69% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $8 | $8.22 | -2.68% | 20 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $213 | $167.81 | +26.93% | 24 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $18 | $15.56 | +15.68% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $338 | $282.08 | +19.82% | 18 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 | $7.58 | -20.84% | 58 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $17.31 | +142.63% | 9 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $251 → $255 | $222.74 | +14.48% | 38 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $37 → $23 | $21.30 | +7.98% | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $419 | $455.66 | -8.05% | 14 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $9 | $5.21 | +72.74% | 19 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.08 | +195.28% | 21 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $25.07 | n/a | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $85.04 | n/a | 1 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.01 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 | $175.06 | n/a | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0001 | n/a | 3 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $250 | $0.0001 | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $1.3 | $0.0001 | n/a | 8 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $415 | $406.68 | n/a | 6 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $360 → $395 | $394.82 | n/a | 5 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $28.54 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $80 | $63.68 | n/a | 4 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $410 → $460 | $360.72 | n/a | 7 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 → $210 | $197.42 | n/a | 5 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $29 | $38.68 | n/a | 4 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $18.44 | n/a | 1 | Feb 25, 2014 |
McKesson
Jun 18, 2026
Maintained: Buy
Price Target: $1,012
Current: $744.85
Upside: +35.87%
BrightSpring Health Services
Jun 18, 2026
Rated: Buy
Price Target: $65 → $81
Current: $67.20
Upside: +20.54%
Charles River Laboratories International
Jun 4, 2026
Reiterated: Buy
Price Target: $235
Current: $181.56
Upside: +29.43%
Veeva Systems
Jun 4, 2026
Maintained: Buy
Price Target: $300 → $235
Current: $153.16
Upside: +53.43%
Cencora
Jun 1, 2026
Rated: Buy
Price Target: $400
Current: $271.28
Upside: +47.45%
ICON Public Limited Company
Jun 1, 2026
Rated: Buy
Price Target: $120 → $164
Current: $140.73
Upside: +16.54%
Veradigm Inc.
May 27, 2026
Reiterated: Buy
Price Target: $8
Current: $5.00
Upside: +60.00%
DarioHealth
May 13, 2026
Maintained: Hold
Price Target: $11
Current: $6.43
Upside: +71.07%
CVS Health
May 11, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $101.30
Upside: +8.59%
Evolent Health
May 11, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $4.48
Upside: +78.57%
May 11, 2026
Rated: Buy
Price Target: $3 → $4
Current: $2.57
Upside: +55.64%
May 7, 2026
Maintained: Buy
Price Target: $53
Current: $34.71
Upside: +52.69%
May 6, 2026
Rated: Hold
Price Target: $5 → $8
Current: $8.22
Upside: -2.68%
May 5, 2026
Maintained: Buy
Price Target: $213
Current: $167.81
Upside: +26.93%
May 5, 2026
Rated: Buy
Price Target: $15 → $18
Current: $15.56
Upside: +15.68%
May 4, 2026
Rated: Buy
Price Target: $338
Current: $282.08
Upside: +19.82%
May 4, 2026
Rated: Hold
Price Target: $6
Current: $7.58
Upside: -20.84%
May 4, 2026
Reiterated: Buy
Price Target: $42
Current: $17.31
Upside: +142.63%
May 1, 2026
Rated: Buy
Price Target: $251 → $255
Current: $222.74
Upside: +14.48%
Apr 30, 2026
Rated: Hold
Price Target: $37 → $23
Current: $21.30
Upside: +7.98%
Apr 23, 2026
Maintained: Hold
Price Target: $419
Current: $455.66
Upside: -8.05%
Feb 20, 2026
Maintained: Buy
Price Target: $6 → $9
Current: $5.21
Upside: +72.74%
Nov 13, 2025
Maintained: Buy
Price Target: $15
Current: $5.08
Upside: +195.28%
Jun 11, 2025
Reiterated: Buy
Price Target: $90
Current: $25.07
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $51
Current: $85.04
Upside: n/a
Sep 9, 2024
Reiterated: Buy
Price Target: n/a
Current: $14.01
Upside: n/a
Oct 30, 2023
Maintained: Buy
Price Target: $170
Current: $175.06
Upside: n/a
Dec 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 16, 2022
Maintained: Buy
Price Target: $2 → $250
Current: $0.0001
Upside: n/a
May 17, 2022
Maintained: Sell
Price Target: $9 → $1.3
Current: $0.0001
Upside: n/a
Apr 16, 2021
Maintained: Buy
Price Target: $370 → $415
Current: $406.68
Upside: n/a
Apr 14, 2021
Maintained: Buy
Price Target: $360 → $395
Current: $394.82
Upside: n/a
Mar 29, 2021
Initiated Coverage: Hold
Price Target: $29
Current: $28.54
Upside: n/a
Feb 8, 2021
Maintained: Buy
Price Target: $74 → $80
Current: $63.68
Upside: n/a
Feb 1, 2021
Maintained: Hold
Price Target: $410 → $460
Current: $360.72
Upside: n/a
Jun 16, 2020
Upgraded: Buy
Price Target: $200 → $210
Current: $197.42
Upside: n/a
Oct 30, 2015
Maintained: Hold
Price Target: $30 → $29
Current: $38.68
Upside: n/a
Feb 25, 2014
Initiated Coverage: Buy
Price Target: $42
Current: $18.44
Upside: n/a